Research Programs

Cancer Biology

Members of the Cancer Biology program aim to discover basic biological processes that promote cancer risk, development, and progression, leading to more effective strategies to prevent, diagnose, and treat cancer across populations.

Explore the Cancer Biology Program

Cancer Control

The Cancer Control Program fosters and facilitates research designed to reduce cancer risk, improve outcomes and quality of life, and eliminate disparities across the cancer care continuum.

Learn about the Cancer Control Program

Discovery and Developmental Therapeutics

Members of the Discovery and Developmental Therapeutics program aim to translate the most promising scientific discoveries into clinical practice.

Explore Discovery and Developmental Therapeutics

Integrated Disease-Oriented Teams

Research programs are further enhanced by 16 integrated Disease-Oriented Teams (iDOTs) comprised of basic, translational, clinical, and population health scientists focused on specific disease areas. Through multi-disciplinary collaboration, these teams hold the shared goal of translating discoveries into new treatments and therapies.

Cancer Biology

Cancer Control

Discovery and Developmental Therapeutics

Integrated Disease-Oriented Teams

Deepak Kilari, MD

Chair, Adult Early Phase

Mehdi Hamadani, MD

Chair, Bone Marrow Transplant/Cell Therapy

Tina Yen, MD, MS, FACS, FSSO

Chair, Breast

Jennifer Connelly, MD

Chair, Central Nervous System

William Hall, MD

Chair, Gastrointestinal

Peter Langenstroer, MD, MS

Chair, Genitourinary

Denise Uyar, MD

Chair, Gynecology

Stuart Wong, MD

Chair, Head and Neck

Guru Subramanian Guru Murthy, MD, MS

Chair, Leukemia

Timothy Fenske, MD, MS

Chair, Lymphoma

Michael James Burke, MD

Chair, Pediatrics

Anita D'Souza, MD

Chair, Plasma Cell Disorders

Jennifer Knight, MD, MS, FACLP

Chair, Population Sciences and Behavioral Health

Meena Bedi, MD, MS

Chair, Sarcoma

Callisia Clarke, MD, MS, FACS, FSSO

Chair, Skin

Lindsay Puckett, MD

Chair, Thoracic